fluorescein-5-isothiocyanate has been researched along with fenofibric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corraliza, L; Garcia-Ramírez, M; Hernández, C; Simó, R; Villarroel, M | 1 |
| Guo, W; Hernández, C; Roy, S; Simó, R; Trudeau, K; Villarroel, M | 1 |
| Hernández, C; Kim, D; Roy, S; Simó, R | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and fenofibric acid
| Article | Year |
|---|---|
Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.
Topics: Aged; AMP-Activated Protein Kinases; Biological Transport; Blood-Retinal Barrier; Cell Line; Cell Membrane Permeability; Dextrans; Diabetic Retinopathy; Dose-Response Relationship, Drug; Fenofibrate; Fluorescein-5-isothiocyanate; Glucose; Humans; Hypolipidemic Agents; Interleukin-1beta; Macular Edema; Retinal Pigment Epithelium; Tight Junctions | 2011 |
Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.
Topics: Anticholesteremic Agents; Blotting, Western; Capillary Permeability; Cells, Cultured; Claudin-1; Collagen Type IV; Dextrans; Diabetes Complications; Dose-Response Relationship, Drug; Fenofibrate; Fibronectins; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Glucose; Humans; Interleukin-1beta; Membrane Proteins; Microscopy, Confocal; Phosphoproteins; Retinal Pigment Epithelium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Up-Regulation; Zonula Occludens-1 Protein | 2011 |
Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.
Topics: Animals; Anticholesteremic Agents; Blotting, Western; Capillary Permeability; Cells, Cultured; Collagen Type IV; Cyclooxygenase 2; Diabetic Retinopathy; Endothelium, Vascular; Fenofibrate; Fibronectins; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Microscopy, Fluorescence; Rats; Retinal Vessels; Zonula Occludens-1 Protein | 2015 |